Physician profile
Daniela Matijevich
NPI 1386104826
$1,425.89
in general payments reported to CMS, 2019-2025
11 companies · $631 in 2025
The $631 reported for 2025 was more than what 78% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $109 · 2023: $413 · 2024: $273 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $979.01 | 2023-2025 | Via Matrix, Puraply, Simplimax |
| Stryker Corporation | $219.02 | 2022-2025 | Salvation, Inbone, N/A |
| Depuy Synthes Sales INC. | $40.45 | 2023 | Fibergraft Bg Morsels, Na, Fibulink |
| Treace Medical Concepts, INC. | $40.33 | 2023-2024 | |
| Djo, LLC | $35.40 | 2023-2025 | Donjoy, Cmf |
| Integra Lifesciences Corporation | $32.90 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $22.45 | 2022 | |
| Horizon Therapeutics Plc | $18.59 | 2022 | |
| Orthofix Medical, INC. | $14.90 | 2023 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2023 | Seglentis |
| Grt US Holding, INC. | $10.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Matijevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.